Hypoxia and hypoxia inducible factors in cancer stem cell maintenance

Current Topics in Microbiology and Immunology

Volumn 345, Issue 1, 2010, Pages 21-30

  Li, Zhizhong ^a   Rich, Jeremy N ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; OXYGEN; PLATELET DERIVED GROWTH FACTOR; TRANSCRIPTION FACTOR NANOG; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN CONTAINING PROTEIN 1; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1;

ARTICLE; BRAIN CANCER; BREAST CANCER; CANCER INVASION; CANCER STEM CELL; CARCINOGENESIS; CELL DIFFERENTIATION; CELL HYPOXIA; CELL PROLIFERATION; CELL RENEWAL; COLON CANCER; GLIOMA; HUMAN; KIDNEY CANCER; LIVER CELL CARCINOMA; LUNG NON SMALL CELL CANCER; NEUROBLASTOMA; OXYGEN TENSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; STEM CELL NICHE; TUMOR GROWTH; TUMOR NECROSIS; TUMOR VASCULARIZATION; ANIMAL; METABOLISM; PHYSIOLOGY; REVIEW;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL HYPOXIA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASTIC STEM CELLS;

EID: 78349257041     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/82-2010-75     Document Type: Article

References (59)

1. Acker T, Diez-Juan A et al (2005) Genetic evidence for a tumor suppressor role of HIF-2alpha. Cancer Cell 8(2):131-141 (Pubitemid 41132742)
2. Al-Hajj M, Wicha MS et al (2003) Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100(7):3983-3988 (Pubitemid 36418143)
3. Axelson H, Fredlund E et al (2005) Hypoxia-induced dedifferentiation of tumor cells-a mechanism behind heterogeneity and aggressiveness of solid tumors. Semin Cell Dev Biol 16(4-5):554-563 (Pubitemid 41247879)
4. Bangoura G, Liu ZS et al (2007) Prognostic significance of HIF-2alpha/EPAS1 expression in hepatocellular carcinoma. World J Gastroenterol 13(23):3176-3182 (Pubitemid 47064579)
5. Bao S, Wu Q et al (2006a) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444(7120):756-760 (Pubitemid 44949604)
6. Bao S, Wu Q et al (2006b) Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66(16):7843-7848 (Pubitemid 44299144)
7. Bertout JA, Majmundar AJ et al (2009) HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses. Proc Natl Acad Sci USA 106(34):14391-14396
8. Bertout JA, Patel SA et al (2008) The impact of O2 availability on human cancer. Nat Rev Cancer 8(12):967-975
9. Bolos V, BlancoMet al (2009) Notch signalling in cancer stemcells. Clin Transl Oncol 11(1):11-19
10. Bonnet D, Dick JE (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3(7):730-737 (Pubitemid 27298715)
11. Calabrese C, Poppleton H et al (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11(1):69-82 (Pubitemid 46054518)
12. Carroll VA, Ashcroft M (2006) Role of hypoxia-inducible factor (HIF)-1alpha versus HIF-2alpha in the regulation of HIF target genes in response to hypoxia, insulin-like growth factor-I, or loss of von Hippel-Lindau function: implications for targeting the HIF pathway. Cancer Res 66 (12):6264-6270
13. Chow DC, Wenning LA et al (2001) Modeling pO(2) distributions in the bone marrow hematopoietic compartment. II. Modified Kroghian models. Biophys J 81(2):685-696 (Pubitemid 32721444)
14. Clement V, Sanchez P et al (2007) HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 17(2):165-172 (Pubitemid 46107823)
15. Conrad PW, Freeman TL et al (1999) EPAS1 trans-activation during hypoxia requires p42/p44 MAPK. J Biol Chem 274(47):33709-33713 (Pubitemid 129511686)
16. Covello KL, Kehler J et al (2006) HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev 20(5):557-570 (Pubitemid 43345322)
17. Danet GH, Pan Y et al (2003) Expansion of human SCID-repopulating cells under hypoxic conditions. J Clin Invest 112(1):126-135 (Pubitemid 38056384)
18. Ema M, Taya S et al (1997) A novel bHLH-PAS factor with close sequence similarity to hypoxiainducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA 94(9):4273-4278
19. Ezashi T, Das P et al (2005) Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci USA 102(13):4783-4788 (Pubitemid 40471531)
20. Giatromanolaki A, Koukourakis MI et al (2001) Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer 85(6):881-890 (Pubitemid 33010557)
21. Gilbertson RJ, Rich JN (2007) Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nat Rev Cancer 7(10):733-736 (Pubitemid 47463683)
22. Gordan JD, Bertout JA et al (2007) HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 11(4):335-347 (Pubitemid 46518312)
23. Gustafsson MV, Zheng X et al (2005) Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell 9(5):617-628 (Pubitemid 41555144)
24. Harris AL (2002) Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2(1): 38-47 (Pubitemid 37328806)
25. Heddleston JM, Li Z et al (2009) The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 8 (20):3274-3284
26. Helczynska K, Larsson AM et al (2008) Hypoxia-inducible factor-2alpha correlates to distant recurrence and poor outcome in invasive breast cancer. Cancer Res 68(22):9212-9220
27. Hockel M, Vaupel P (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93(4):266-276 (Pubitemid 32219813)
28. Hoffmann AC, Mori R et al (2008) High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF. Neoplasia 10(7):674-679 (Pubitemid 351883883)
29. Holmquist-Mengelbier L, Fredlund E et al (2006) Recruitment of HIF-1alpha and HIF-2alpha to common target genes is differentially regulated in neuroblastoma: HIF-2alpha promotes an aggressive phenotype. Cancer Cell 10(5):413-423 (Pubitemid 44693470)
30. Ivan M, Kondo K et al (2001) HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292(5516):464-468 (Pubitemid 32335941)
31. Jaakkola P, Mole DR et al (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292(5516):468-472 (Pubitemid 32335942)
32. Kaur B, Khwaja FW et al (2005) Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol 7(2):134-153 (Pubitemid 40590514)
33. Kiel MJ, Morrison SJ (2008) Uncertainty in the niches that maintain haematopoietic stem cells. Nat Rev Immunol 8(4):290-301 (Pubitemid 351432804)
34. Kimura H, Braun RD et al (1996) Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res 56(23):5522-5528 (Pubitemid 27011389)
35. Li Z, Bao S et al (2009) Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15(6):501-513
36. Makino Y, Cao R et al (2001) Inhibitory PAS domain protein is a negative regulator of hypoxiainducible gene expression. Nature 414(6863):550-554 (Pubitemid 33131538)
37. Malanchi I, Peinado H et al (2008) Cutaneous cancer stem cell maintenance is dependent on betacatenin signalling. Nature 452(7187):650-653 (Pubitemid 351483363)
38. Maxwell PH, Wiesener MS et al (1999) The tumour suppressor protein VHL targets hypoxiainducible factors for oxygen-dependent proteolysis. Nature 399(6733):271-275 (Pubitemid 29246458)
39. O'Brien CA, Pollett A et al (2007) A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445(7123):106-110 (Pubitemid 46067310)
40. Perry JM, Li L (2007) Disrupting the stem cell niche: good seeds in bad soil. Cell 129(6):1045-1047 (Pubitemid 46891049)
41. Pietras A, Hansford LM et al (2009) HIF-2alpha maintains an undifferentiated state in neural crest-like human neuroblastoma tumor-initiating cells. Proc Natl Acad Sci USA 106 (39):16805-16810
42. Pouyssegur J, Dayan F et al (2006) Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441(7092):437-443 (Pubitemid 44050138)
43. Reya T, Morrison SJ et al (2001) Stem cells, cancer, and cancer stem cells. Nature 414 (6859):105-111 (Pubitemid 33041634)
44. Schwarz G (1909) Ueber Desensibilisierung gegen röntgen-und radiumstrahlen. Munchener Medizinische Wochenschrift 24:1-2
45. Shen Q, Wang Y et al (2008) Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions. Cell Stem Cell 3(3):289-300
46. Singh SK, Clarke ID et al (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63(18):5821-5828 (Pubitemid 37187480)
47. Soeda A, Park M et al (2009) Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha. Oncogene 28(45):3949-3959
48. Studer L, Csete M et al (2000) Enhanced proliferation, survival, and dopaminergic differentiation of CNS precursors in lowered oxygen. J Neurosci 20(19):7377-7383
49. Tang W, Zeve D et al (2008) White fat progenitor cells reside in the adipose vasculature. Science 322(5901):583-586
50. Tavazoie M, Van der Veken L et al (2008) A specialized vascular niche for adult neural stem cells. Cell Stem Cell 3(3):279-288
51. Vaupel P, Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26(2):225-239 (Pubitemid 47101660)
52. Wang V, Davis DA et al (2005) Differential gene up-regulation by hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2alpha in HEK293T cells. Cancer Res 65(8):3299-3306 (Pubitemid 40524614)
53. Warburg O (1956) On the origin of cancer cells. Science 123(3191):309-314
54. Wion D, Christen T et al (2009) PO(2) matters in stem cell culture. Cell Stem Cell 5(3):242-243
55. Yang MH, Wu MZ et al (2008) Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 10(3):295-305
56. Yoshida S, Sukeno M et al (2007) A vasculature-associated niche for undifferentiated spermatogonia in the mouse testis. Science 317(5845):1722-1726 (Pubitemid 47461832)
57. Yoshida Y, Takahashi K et al (2009) Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5(3):237-241
58. Zhang J, Li L (2008) Stem cell niche: microenvironment and beyond. J Biol Chem 283(15): 9499-9503
59. Zhang Y, GuoWet al (2008) Human colon cancer stem cells locate in hypoxic niche. J Clin Oncol, 2008 ASCO Annual meeting proceedings 26(15S):Abstract 22209